This tumoral heterogeneity renders a high level of plasticity to melanoma tumors to switch between phenotypes of proliferation to invasion to stemness, along a high to low MITF gradient [56], thereby abetting the characteristic extreme therapy refractoriness of melanoma. The gene discussed is MITF; the disease is melanoma.